Emles at Home ETF (AMEX:LIV)
Historical Stock Chart
From Jan 2020 to Jan 2025
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a
developer of innovative drugs, announced today, its shareholders are
invited to the Annual Shareholders Meeting on Wednesday, May 31, 2006
10 a.m. at the Sterling Club, Turnberry Towers, 2827 Paradise Rd., Las
Vegas, Nevada.
Additionally, Samaritan will host an "open house" reception for
its shareholders on May 30, 2006, the evening before, from 5 p.m. to 7
p.m. at its expanded corporate offices 101 Convention Center Dr. Ste.
310, Las Vegas, NV. Samaritan will also informally present an in-depth
view of its innovative drug pipeline for interested shareholders.
Samaritan Pharmaceuticals: "We LIV....to Save Lives."
Samaritan is a small-cap Biotech, driven to discover, develop and
commercialize innovative therapeutics' for AIDS, Alzheimer's, Cancer
and Heart disease patients. Look at www.samaritanpharma.com. Please
register on Website so we can notify you of upcoming conference calls,
news and events.
Disclaimer
The company disclaims any information that is created by an
outside party and endorses only information that is communicated by
its press releases, filings and Website. This news release contains
forward-looking statements that reflect management's current beliefs
about the potential for its drug candidates, science and technology.
However, as with any biopharmaceutical under development, there are
significant risks and uncertainties in the process of development and
regulatory review. There are no guarantees that products will prove to
be commercially successful. For additional information about the
factors that affect the company's business, please read the company's
latest Form 10-K filed April 15, 2005. The company undertakes no duty
to update forward-looking statements.